GH Research PLC (GHRS)
10.51
+0.01
(+0.10%)
USD |
NASDAQ |
Apr 26, 16:00
10.51
0.00 (0.00%)
After-Hours: 20:00
GH Research Free Cash Flow: -33.44M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -33.44M |
| September 30, 2023 | -32.21M |
| June 30, 2023 | -29.92M |
| March 31, 2023 | -27.16M |
| December 31, 2022 | -26.27M |
| September 30, 2022 | -23.16M |
| June 30, 2022 | -24.36M |
| Date | Value |
|---|---|
| March 31, 2022 | -20.29M |
| December 31, 2021 | -15.39M |
| September 30, 2021 | -11.67M |
| June 30, 2021 | -2.538M |
| March 31, 2021 | -1.315M |
| December 31, 2020 | -0.33M |
Free Cash Flow Range, Past 5 Years
-33.44M
Minimum
Dec 2023
-0.33M
Maximum
Dec 2020
-19.08M
Average
-23.16M
Median
Sep 2022
Free Cash Flow Benchmarks
| Amarin Corp PLC | 6.347M |
| Jazz Pharmaceuticals PLC | 1.049B |
| Prothena Corp PLC | -136.72M |
| Iterum Therapeutics PLC | -39.34M |
| Mural Oncology PLC | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.085M |
| Cash from Investing (Quarterly) | -0.024M |
| Cash from Financing (Quarterly) | -0.041M |
| Free Cash Flow Per Share (Quarterly) | -0.1559 |
| Free Cash Flow Yield | -6.12% |